Carbamazepine, HLA-B*1502 and risk of Stevens––Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

Author: Ferrell P Brent   McLeod Howard L  

Publisher: Future Medicine

ISSN: 1462-2416

Source: Pharmacogenomics, Vol.9, Iss.10, 2008-10, pp. : 1543-1546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content